Search clinical trials for: Clopidogrel

Total 800 results

Region Skane
AstraZeneca; IHF GmbH - Institut für Herzinfarktforschung; Hippocrates Research; IRW consulting...

Withdrawn

Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention. (AUGEAS)

Diabetes Mellitus | Microvascular Coronary Artery Disease
Hospital Clinic of Barcelona
AstraZeneca

Completed

TIcaGrEloR and ABSORB Bioresorbable Vascular Scaffold Implantation for Recovery of Vascular Function After Successful Chronic Total Occlusion Recanalization (TIGER-BVS)

Patients Who Are Scheduled to Undergo a PCI (Percutaneous Coronary Intervention) for CTO (Chronic Total Occlusion)

Spain
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management (TICA KOREA)

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Angina Pectoris | Acute Coronary Syndrome

Korea, Republic of
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers

Healthy

United States
Daewoong Pharmaceutical Co. LTD.

Unknown

Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease

MCA - Middle Cerebral Artery Dissection

Korea, Republic of
AstraZeneca

Completed

Clopidogrel Bioequivalence Study in Healthy Subjects

Bioequivalence, AUC, Cmax, Pharmacokinetics

Germany
Emory University

Completed

Investigation of the Athero-Protective Effects of Clopidogrel (APECS)

Coronary Artery Disease

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting Conditions

Fasting

India
Assistance Publique - Hôpitaux de Paris

Completed

Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy Subjects

Healthy

France
Tabula Rasa HealthCare

Active, not recruiting

Type 2 Diabetes With Antiplatelet Drugs

Myocardial Infarction | Heart Failure | Type2 Diabetes | Antiplatelet Drugs

United States
AstraZeneca

Completed

A Pharmacodynamic Study With Ticagrelor in African American Patients

Stable Coronary Artery Disease

United States
Daiichi Sankyo, Inc.

Completed

Phase 1 Study to Evaluate the Safety and Tolerability of DS-1040b IV Infusion With Clopidogrel in Healthy Subjects

Drug Interaction

United Kingdom
Zealand University Hospital

Terminated

RIsk of Apoplexia Cerebri in CLOpidogrel Non-responders (RISCLON)

Stroke

Denmark
University of Florida

Recruiting

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI (TAILOR BLEED)

Coronary Artery Disease

United States
Assistance Publique - Hôpitaux de Paris
Fonds de Dotation ACTION

Not yet recruiting

Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome (ADEN)

MYOCARDIAL INFARCTION

France
McGill University Health Centre/Research Institute...
Canadian Institutes of Health Research (CIHR)

Completed

Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes (TC4)

Acute Coronary Syndrome

Canada
Jiangsu HengRui Medicine Co., Ltd.

Completed

To Evaluate the Safety and Tolerability of Combined Administration of SHR2285 Tablets With Aspirin, Clopidogrel or Ticagrelor in Healthy Subjects

Thrombosis

China
Beijing Neurosurgical Institute

Completed

Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms (APISIA Trail)

Stents | Unruptured Intracranial Aneurysm | Antiplatelet Drugs

China
Beijing Tiantan Hospital
University of California, San Francisco

Completed

Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events (CHANCE)

Stroke | Transient Ischemic Attack

China
Asan Medical Center
Korea Otsuka International Asia Arab

Completed

Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II (TOSS-2)

Atherosclerosis | Cerebral Infarction

Philippines, Korea, Republic of, Thailand, Hong Kong
Yale University
American Heart Association

Completed

Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects

Healthy Subjects

United States
IHF GmbH - Institut für Herzinfarktforschung
OrbusNeich

Withdrawn

COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials (COSTA)

Coronary Disease | Stable Angina | Unstable Angina | STEMI | NSTEMI

Germany
Liverpool University Hospitals NHS Foundation Trust
Liverpool Heart and Chest Hospital NHS Foundation Trust; Countess of Chester... and other collaborators

Completed

The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome (ROBOT-ACS)

Bleeding | Acute Coronary Syndrome | Ticagrelor | Clopidogrel | Novel Anti-platelets

United Kingdom
First Affiliated Hospital of Harbin Medical University

Completed

Rapid P2Y12 Receptor Inhibition Attenuates Inflammatory Cell Infiltration in Thrombus Aspirated From the STEMI Patients

Inflammation | Thrombosis
Deutsches Herzzentrum Muenchen
Technical University of Munich

Completed

75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)

Coronary Disease

Germany
Yonsei University

Not yet recruiting

Dual Antiplatelet Therapy in Patients With Clopidogrel Resistance Following Off-Pump Coronary Artery Bypass

Multi Vessel Coronary Artery Disease

Korea, Republic of
University of Florida
AstraZeneca

Completed

Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI (OPTIMUS-6)

Coronary Artery Disease | Diabetes Mellitus, Type 2

United States
Medical University of Warsaw
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Completed

Antiplatelet Therapy Effect on Extracellular Vesicles in Acute Myocardial Infarction (AFFECT EV)

Myocardial Infarction

Netherlands, Poland
The Medicines Company

Completed

Appraisal of MDCO-157 and Plavix® Pharmacokinetics and Pharmacodynamics in Healthy Volunteers With an Evaluation (AMPHORE)

Pharmacokinetics and Pharmacodynamics in Healthy Volunteers

France
Trans Tasman Radiation Oncology Group
National Health and Medical Research Council, Australia; Novartis Pharmaceuticals and other collaborators

Completed

RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

Prostate Cancer

Australia, New Zealand
Unity Health Toronto
Prairie Vascular Research Inc.

Completed

Ticagrelor for PCI Post Thrombolysis (SETFAST)

Acute Myocardial Infarction

Canada
Michael Wolzt, Prof. MD

Completed

The Effect of Ticagrelor or Clopidogrel on Endothelial Function During Acute and Chronic Treatment

Ischemia

Austria
University of Patras

Completed

Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI) (PRO-GR-4)

Myocardial Infarction

Greece
University of Patras

Completed

Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis

Hemodialysis | Chronic Renal Failure

Greece
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI); Spartan Bioscience Inc.; Applied...

Completed

Tailored Antiplatelet Therapy Following PCI (TAILOR-PCI)

Coronary Artery Disease | Acute Coronary Syndrome | Stenosis

United States, Korea, Republic of, Canada, Mexico
University of Florida

Completed

Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease (SWAP-4)

Coronary Artery Disease

United States
Baylor College of Medicine

Withdrawn

The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and Inflammation

Atherosclerosis

United States
First Affiliated Hospital of Harbin Medical University

Unknown

Half-dose Ticagrelor Overcomes High-dose Clopidogrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity

Coronary Artery Disease | Clopidogrel, Poor Metabolism of

United States
Medical Center of South Arkansas

Withdrawn

Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis (TACAT)

Acute Coronary Syndrome | Acute ST Segment Elevation Myocardial Infarction

United States
Yongjian Wu

Unknown

Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel

Coronary Disease

China
Catholic University of the Sacred Heart

Terminated

Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACS (TIGER-M)

Non ST Segment Elevation Acute Coronary Syndrome

Italy
Kyunghee University Medical Center

Unknown

Genotype and Platelet Reactivity in Patients on Hemodialysis

Chronic Kidney Disease

Korea, Republic of
Assistance Publique Hopitaux De Marseille

Completed

Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention

Acute Coronary Syndromes

France
Gennaro Sardella

Completed

Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE Trial (RESET GENE)

Acute Coronary Syndrome

Italy
Seoul National University Bundang Hospital
Seoul St. Mary's Hospital; Asan Medical Center; Seoul National University Hospital and other collaborators

Recruiting

Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling

Endovascular Procedures | Aneurysm Cerebral

Korea, Republic of
Second Affiliated Hospital, School of Medicine,...

Recruiting

Sequential MonotherApy of TicagrElor and Clopidogrel After Coronary Intervention (MATE)

Acute Coronary Syndrome | Percutaneous Coronary Intervention

China
Peking Union Medical College Hospital

Recruiting

Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention (APLABE-PCI)

Coronary Artery Disease | Percutaneous Coronary Intervention

China
Xuanwu Hospital, Beijing

Completed

The Carotid and Middle Cerebral Artery Occlusion Surgery Study (CMOSS)

Stroke | Carotid Artery Occlusion | Middle Cerebral Artery Occlusion

China
Beijing Tiantan Hospital
Beijing Municipal Science & Technology Commission

Completed

Platelet Reactivity in Acute Non-disabling Cerebrovascular Events (PRINCE)

Stroke | Ischemic Attack, Transient

China
Xinhua Hospital, Shanghai Jiao Tong University...

Unknown

Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke

Ischemic Stroke | Antiplatelet Effect

China

Search clinical trials for: Clopidogrel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations